French version of FACT-G: Validation and comparison with other cancer-specific instruments

被引:61
作者
Conroy, T [1 ]
Mercier, M
Bonneterre, J
Luporsi, E
Lefebvre, JL
Lapeyre, M
Puyraveau, M
Schraub, S
机构
[1] Ctr Alexis Vautrin, Dept Med Oncol, F-54500 Vandoeuvre Les Nancy, France
[2] Med Pharmaceut Univ, Besancon, France
[3] Ctr Oscar Lambret, F-59020 Lille, France
[4] Ctr Paul Str, Strasbourg, France
关键词
validation; quality of life; FACT-G; EORTC QLQ-C30; FLIC; breast cancer; colorectal cancer; head and neck cancer;
D O I
10.1016/j.ejca.2004.06.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to assess the validity of the French version of the Functional Assessment of Cancer Therapy - General (FACT-G), and to compare its psychometric properties with those of two other cancer-specific quality of life questionnaires, European Organisation for Research and Treatment of Cancer Quality of Life - Core 30 (EORTC QLQ-C30) and Functional Living Index - Cancer (FLIC). Two hundred and twenty three patients with breast or colorectal cancer completed the FACT-G questionnaire in French followed by (in random order) the QLQ-C30 and FLIC. An additional 87 patients with head and neck (H&N) cancer completed the FACT-H&N followed by the QLQ-C30 and H&N-Besanqon. The French version of FACT-G was internally consistent, and its reproducibility was excellent. FACT-G Physical Well-Being and global scores correlated with all QLQ-C30 subscales. There was evidence of discriminant validity. Compared with the other tools, FACT-G included a statistically significantly higher proportion of items patients considered to be confusing or upsetting. Patients with breast or colorectal cancer expressed a preference for QLQ-C30. Use of the specific H&N additional items increased the responsiveness to change of FACT-G. The French version of FACT-G is valid and has psychometric properties similar to those of FLIC and QLQ-C30. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2243 / 2252
页数:10
相关论文
共 25 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   A prospective study of quality of life in head and neck cancer patients.: Part II:: Longitudinal data [J].
Bjordal, K ;
Ahlner-Elmqvist, M ;
Hammerlid, E ;
Boysen, M ;
Evensen, JF ;
Biörklund, A ;
Jannert, M ;
Westin, T ;
Kaasa, S .
LARYNGOSCOPE, 2001, 111 (08) :1440-1452
[3]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[4]  
Bottomely, 2001, EORTC QLQC30 SCORING
[5]   CONVERGENT AND DISCRIMINANT VALIDATION BY THE MULTITRAIT-MULTIMETHOD MATRIX [J].
CAMPBELL, DT ;
FISKE, DW .
PSYCHOLOGICAL BULLETIN, 1959, 56 (02) :81-105
[6]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[7]  
Cohen J, 1998, STAT POWER ANAL BEHA
[8]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[9]  
*FACIT, 1997, FACIT MAN
[10]   Using reference data on quality of life - the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3) [J].
Hjermstad, MJ ;
Fayers, PM ;
Bjordal, K ;
Kaasa, S .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (09) :1381-1389